Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.012 seconds
Permar, P.H.; Boulogne, A.R.; Mosley, W.C. Jr.; Walker, V.W.
Du Pont de Nemours (E.I.) and Co., Aiken, S.C. (USA). Savannah River Lab1976
Du Pont de Nemours (E.I.) and Co., Aiken, S.C. (USA). Savannah River Lab1976
AbstractAbstract
[en] Californium-252 neutron sources have been developed to investigate the value of this radionuclide in cancer therapy. The primary objective of the neutron source development is to meet the changing needs of the radiotherapist with safe, reliable, and uniform products. Thus far point and line sources containing 0.5 microgram to 1.0 milligram of californium-252 have been designed. The neutron source forms that are now available are reviewed, and the techniques by which they are fabricated are discussed. Many new combinations and configurations of californium-252 neutron sources are possible, if needed by the medical evaluators of this radioisotope. Californium-252 neutron sources are loaned by the United States Energy Research and Development Administration (ERDA) for medical research. Californium-252 sources are also loaned by ERDA for clinical investigations under a protocol of the Radiation Therapy Oncology Group, U.S. National Cancer Institute
Primary Subject
Secondary Subject
Source
1976; 29 p; International symposium on californium-252 utilization; Paris, France; 26 Apr 1976; CONF-760436--7; Available from NTIS. $4.00.
Record Type
Report
Literature Type
Conference
Report Number
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue